HOME >> BIOLOGY >> NEWS
Atherosclerosis treatment needs to go with the flow

Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.

Studies have shown that using a stent to open a blocked blood vessel is generally more successful that balloon angioplasty, when one is treating a lesion in non-bifurcated area. Current data, however, indicate no such superiority in the use of stents to treat lesions in branching passages. Yoram Richter and colleagues, from HarvardM.I.T. Division of Health Sciences and Technology, provide a hemodynamic analysis (an analysis of the forces of blood flow) in the region of the bifurcated vasculature to show that stenting of both passages results in a blood flow pattern that is inherently harmful to the main branch, and results in rapid re-occlusion of the main branch. To investigate this system, the authors developed a new dynamic bench top fluid mechanical model system.

This system provides a major advance over previous static models by allowing not only the prediction of areas in the blood vessels likely to be damaged, but also by reflecting the true active nature of the arterial system that compensates for and minimizes any disturbance. The authors further tested their in vitro predictions in an animal model, and, in seeing in the animals what was predicted to occur from their bench top model, established the strength of their in vitro modeling system. This study provides an explanation for why stenting in forked blood vessel regions has had a low success rate, and also provides a direction for appropriate treatment of these commonly blocked regions.

An accompanying commentary from R. Wayne Alexander at Emory University, provides a detailed look at the stent methodologies for treating occluded arter
'"/>

Contact: Laurie Goodman
press_releases@the-jci.org
212-342-4159
Journal of Clinical Investigation
1-Jun-2004


Page: 1 2

Related biology news :

1. New Discovery Offers Hope For Controlling Cholesterol, Atherosclerosis
2. UCSF Researchers Identify Molecule Involved In Early Stage Of Atherosclerosis In Mice
3. Wistar Scientist To Speak At Toxicology Forum On Effects Of Conjugated Linoleic Acid On Preventing And Reversing Atherosclerosis
4. Soy Protein With Phytoestrogens Inhibit Atherosclerosis Progression As Well As Premarin
5. Soy Phytoestrogens Reduce Carotid Atherosclerosis As Much As Premarin
6. Induced Mutant Mouse Models Of Lipoprotein Disorders And Atherosclerosis
7. Insulin Resistance Is A Risk Factor For Atherosclerosis In Whites And Hispanics
8. Leader in cancer treatment and prevention research honored
9. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
10. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
11. New treatment for fibromyalgia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... March 30, 2017  On April 6-7, 2017, Sequencing.com ... Genome hackathon at Microsoft,s headquarters in ... will focus on developing health and wellness apps that ... Hack the Genome is the first hackathon for ... world,s largest companies in the genomics, tech and health ...
(Date:3/28/2017)... The report "Video Surveillance Market ... Storage Devices), Software (Video Analytics, VMS), and Service (VSaaS, ... to 2022", published by MarketsandMarkets, the market was valued ... to reach USD 75.64 Billion by 2022, at a ... year considered for the study is 2016 and the ...
(Date:3/23/2017)... -- The report "Gesture Recognition and Touchless Sensing Market by Technology ... Forecast to 2022", published by MarketsandMarkets, the market is expected to be worth ... and 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):
(Date:10/10/2017)... CA (PRWEB) , ... October ... ... a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today ... of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... and business process optimization firm for the life sciences and healthcare industries, announces ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... of medical marijuana products targeting the needs of consumers who are incorporating medical ... takes place in Phoenix, Arizona. , As operators of two successful Valley dispensaries, ...
(Date:10/6/2017)... ... October 06, 2017 , ... ... the healthcare and technology sector at their fourth annual Conference where founders, investors, ... inspiring speakers and the ELEVATE pitch competition showcasing early stage digital health and ...
Breaking Biology Technology:
Cached News: